📋 Bonds
AbbVie Plans $10 Billion Bond Sale to Finance Apogee Therapeutics Acquisition
(1 hour ago)
AbbVie launches a $10 billion bond offering to finance the Apogee Therapeutics deal, marking a major pharmaceutical M&A debt issuance in 2026.